Clinical Trial Update: RCT of Zhi Byed 11 (ZB11) Versus Misoprostol in Tibet [NA]

View source ↗

Summary

A completed randomized trial comparing Zhi Byed 11 (ZB11) to Misoprostol for hemorrhage management in Tibet.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hemorrhage

Drugs mentioned

• MISOPROSTOL (Misoprostol)
• Zhi Byed 11 (ZB11)

Snippet

Sponsor: NICHD Global Network for Women's and Children's Health | Conditions: Hemorrhage | NA | Status: COMPLETED